Journal of Clinical Investigation最新文献

筛选
英文 中文
Transcriptional regulation of NK cell state by ELF4 links innate immune licensing to kidney fibrosis. ELF4对NK细胞状态的转录调节将先天免疫许可与肾纤维化联系起来。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-12 DOI: 10.1172/JCI208155
Shen Li, Hailong Hu, Zachary R Lanzar, Xiangchen Gu, Elisa Cruz-Morales, Audrey C Bochi-Layec, Andrea Sanchez-Navarro, Jihwan Park, Rojesh Shrestha, Hongbo Liu, Aaron J Donner, Meei-Hua Lin, Thomas A Bell, Jeffrey H Miner, Marco Ruella, Eric Vivier, Carrie L Lucas, Christopher A Hunter, Katalin Susztak
{"title":"Transcriptional regulation of NK cell state by ELF4 links innate immune licensing to kidney fibrosis.","authors":"Shen Li, Hailong Hu, Zachary R Lanzar, Xiangchen Gu, Elisa Cruz-Morales, Audrey C Bochi-Layec, Andrea Sanchez-Navarro, Jihwan Park, Rojesh Shrestha, Hongbo Liu, Aaron J Donner, Meei-Hua Lin, Thomas A Bell, Jeffrey H Miner, Marco Ruella, Eric Vivier, Carrie L Lucas, Christopher A Hunter, Katalin Susztak","doi":"10.1172/JCI208155","DOIUrl":"https://doi.org/10.1172/JCI208155","url":null,"abstract":"<p><p>Fibrosis is a common outcome of chronic tissue injury, yet immune regulators that are conserved across species and translatable to human disease remain poorly defined. By integrating human kidney transcriptomes with multiple murine models of kidney fibrosis, we identified the ETS transcription factor ELF4 as a conserved, immune-enriched regulator associated with disease severity. ELF4 expression was highest in natural killer (NK) cells. Genetic deletion of Elf4, including NK cell-specific ablation, attenuated experimental kidney injury, with reduced inflammation, fibrosis, and loss of renal function. Single-cell and functional analyses showed that ELF4 deficiency disrupts late-stage NK cell maturation and broadly suppresses cytotoxic and interferon-γ (IFNγ) effector programs. Mechanistically, ELF4 directly sustains STAT1 transcription, maintaining a STAT1-TBX21 program required for NK cell maturation and effector competence. Consistent with this framework, NK cell depletion, IFNγ neutralization, or antisense-mediated suppression of Elf4 phenocopied renal protection. Together, these findings identify ELF4 as a transcriptional licensing factor that links NK cell state to kidney injury and highlight innate immune programming as a potential therapeutic entry point in chronic kidney disease.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149406484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV-resistant CD19/HIV-targeted dual CAR T cells control HIV replication and B cell lymphoma concurrently in humanized mice. 在人源化小鼠中,抗HIV的CD19/HIV靶向双CAR - T细胞同时控制HIV复制和B细胞淋巴瘤。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-10 DOI: 10.1172/JCI211637
Nan Liu, David Nardo, Vipin Bhardwaj, Joshua Glover, Divanshu Shukla, James L Riley
{"title":"HIV-resistant CD19/HIV-targeted dual CAR T cells control HIV replication and B cell lymphoma concurrently in humanized mice.","authors":"Nan Liu, David Nardo, Vipin Bhardwaj, Joshua Glover, Divanshu Shukla, James L Riley","doi":"10.1172/JCI211637","DOIUrl":"https://doi.org/10.1172/JCI211637","url":null,"abstract":"<p><p>Infusion of CD19-directed chimeric antigen receptor (CAR) T cells (CARTs) can result in robust CART expansion, long-term CART persistence, and durable remissions in B cell malignancies. We hypothesized that leveraging this expansion and persistence could enable sustained HIV control by engineering IL-18 secreting CD19 CARTs to co-express an HIV-specific CAR and a signaling-deficient C34-CXCR4 HIV fusion inhibitor (C34-CXCR4*), thereby generating HIV-resistant CD19/HIV dual CARTs. These CD19/HIV dual CARTs functioned as well as single CAR expressing CARTs toward a single target indicating no loss of activity occurred by co-expressing the CARs in the same cell. In a humanized mouse model of leukemia infused with CD4 T cells from a person with HIV (PWH), autologous CD19/HIV dual CARTs achieved tumor eradication comparable to that of CD19-only CARTs, demonstrating preserved antitumor efficacy. Notably, a CD19.BBζ-IL-18 CAR combined with a CD4.28ζ-C34-CXCR4* HIV-specific CAR exhibited enhanced T cell expansion and persistence and superior HIV and tumor control. Together, these findings identify CD19/HIV dual CARTs as a promising strategy to maintain a robust population of HIV-specific CARTs to control viral rebound, while simultaneously treating B cell malignancies, advancing CART based approaches toward durable HIV remission.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ATRX loss predicts poor outcomes and sensitizes to TEAD inhibition in soft tissue sarcomas. 在软组织肉瘤中,ATRX缺失预示着不良的预后,并对TEAD抑制敏感。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-10 DOI: 10.1172/JCI201343
Ryan A Denu, Anand K Singh, Yingda Jiang, Zhao Zheng, Davis R Ingram, Khalida M Wani, Rossana Lazcano, Madison P Ginn, Kumaren Anand, Bishal K Singh, Jackson C Ballard, Veena Kochat, Biji Chatterjee, William Padron, Sharon M Landers, Angela D Bhalla, Asha S Multani, Sharvari Dharmaiah, Prit Benny Malgulwar, Yiming Cai, Jun Yao, Heather Lin, Jason T Huse, Haoqiang Ying, Emily Z Keung, Wei-Lien Wang, Anthony P Conley, Shreyaskumar Patel, Neeta Somaiah, Ahsan S Farooqi, Alexander J Lazar, Elise F Nassif Haddad, Keila E Torres, Kunal Rai
{"title":"ATRX loss predicts poor outcomes and sensitizes to TEAD inhibition in soft tissue sarcomas.","authors":"Ryan A Denu, Anand K Singh, Yingda Jiang, Zhao Zheng, Davis R Ingram, Khalida M Wani, Rossana Lazcano, Madison P Ginn, Kumaren Anand, Bishal K Singh, Jackson C Ballard, Veena Kochat, Biji Chatterjee, William Padron, Sharon M Landers, Angela D Bhalla, Asha S Multani, Sharvari Dharmaiah, Prit Benny Malgulwar, Yiming Cai, Jun Yao, Heather Lin, Jason T Huse, Haoqiang Ying, Emily Z Keung, Wei-Lien Wang, Anthony P Conley, Shreyaskumar Patel, Neeta Somaiah, Ahsan S Farooqi, Alexander J Lazar, Elise F Nassif Haddad, Keila E Torres, Kunal Rai","doi":"10.1172/JCI201343","DOIUrl":"https://doi.org/10.1172/JCI201343","url":null,"abstract":"<p><p>ATRX is one of the most frequently altered genes in sarcoma and encodes an ATP-dependent chromatin remodeler implicated in maintaining heterochromatin. However, ATRX alterations have not been leveraged for sarcoma treatment. We observed loss of ATRX protein in 14% of soft tissue leiomyosarcoma (STLMS, n =127), 53% of uterine leiomyosarcoma (ULMS, n = 95), 37% of undifferentiated pleomorphic sarcoma (UPS, n = 82), and 8% of dedifferentiated liposarcoma (DDLPS, n = 84). ATRX loss was associated with significantly worse outcomes in ULMS, UPS, and DDLPS. ATRX knockout in sarcoma cells increased proliferation in cooperation with TP53 deletion, chromatin remodeling, and enrichment of PRDM4 and NFIX transcription factor motifs. PRDM4 and NFIX knockdown in ATRX-mutant sarcoma lines resulted in reduced proliferation and invasion, suggesting an epistatic relationship. Consistent with the known and re-demonstrated functional relationship between PRMD4 and YAP1, ATRX loss activated YAP1-TEAD signaling, and ATRX-deficient cells and sarcoma xenografts were more sensitive to the TEAD inhibitors VT103 and IAG933. Overall, our results identify ATRX loss as a prognostic factor of worse outcomes, implicate the ATRX-PRDM4-YAP1-TEAD axis as an underlying mechanism, and suggest use of TEAD inhibition as a potential therapeutic strategy for ATRX-deficient sarcomas.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular senescence mediates facioscapulohumeral muscular dystrophy. 细胞衰老介导面肩肱肌营养不良。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-05 DOI: 10.1172/JCI207716
Usuk Jung, Erdong Wei, Ana Mitanoska, Philipp Heher, Kenric Chen, Haseeb Ahsan, Xu Zhang, Giorgio Tasca, Paul D Robbins, Nathan K LeBrasseur, Michael Kyba, Darko Bosnakovski
{"title":"Cellular senescence mediates facioscapulohumeral muscular dystrophy.","authors":"Usuk Jung, Erdong Wei, Ana Mitanoska, Philipp Heher, Kenric Chen, Haseeb Ahsan, Xu Zhang, Giorgio Tasca, Paul D Robbins, Nathan K LeBrasseur, Michael Kyba, Darko Bosnakovski","doi":"10.1172/JCI207716","DOIUrl":"https://doi.org/10.1172/JCI207716","url":null,"abstract":"<p><p>Facioscapulohumeral muscular dystrophy (FSHD) is driven by aberrant expression of the early embryonic transcription factor Double Homeobox 4 (DUX4), yet the mechanisms linking low, sporadic DUX4 activity to progressive muscle degeneration remain unclear. Here, we identify cellular senescence as a central and early mechanism in FSHD pathogenesis. Analysis of patient muscle transcriptomes revealed strong enrichment of senescence and senescence-associated secretory phenotype (SASP) programs that correlated with DUX4 activity, clinical severity, and histopathological changes. Notably, these signatures were detectable even in STIR-negative muscles, defining a prodystrophic state characterized by early molecular alterations preceding overt MRI-detectable inflammation and highlighting their potential utility as early biomarkers of disease activity. Using an FSHD mouse model, we show that DUX4-induced muscle injury rapidly triggers senescence, which then progressively expands. Fibroadipogenic progenitors and macrophages emerged as the principal senescent populations and key sources of pro-inflammatory and profibrotic SASP signals. Importantly, senescence was therapeutically modifiable. Treatment with the nucleoside reverse transcriptase inhibitor lamivudine (3TC), which inhibits LINE-1 reverse transcriptase activity, significantly reduced senescence, inflammation, and fibrosis while promoting muscle regeneration. These findings identify cellular senescence as a tractable driver of FSHD and warrant senotherapeutic strategies, particularly lamivudine, for clinical intervention in FSHD.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decidua-accumulated effector-like memory CD8+ T cells orchestrate localized antimicrobial defense without compromising fetal tolerance. 蜕膜积累效应样记忆CD8+ T细胞在不影响胎儿耐受性的情况下协调局部抗菌防御。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-05 DOI: 10.1172/JCI202874
Lu Liu, Xixi Huang, Tingxuan Yin, Xianyang Hu, Hailin Yu, Guohua Zhu, Chunfang Xu, Jiajia Chen, Jiangyuan Du, Hongyan Wang, Qingyu Wu, Wei Zhang, Feng Wang, Huimei Wu, Meirong Du
{"title":"Decidua-accumulated effector-like memory CD8+ T cells orchestrate localized antimicrobial defense without compromising fetal tolerance.","authors":"Lu Liu, Xixi Huang, Tingxuan Yin, Xianyang Hu, Hailin Yu, Guohua Zhu, Chunfang Xu, Jiajia Chen, Jiangyuan Du, Hongyan Wang, Qingyu Wu, Wei Zhang, Feng Wang, Huimei Wu, Meirong Du","doi":"10.1172/JCI202874","DOIUrl":"https://doi.org/10.1172/JCI202874","url":null,"abstract":"<p><p>Deciphering immune privilege at the maternal-fetal interface is essential for understanding how reproductive success and host defense are simultaneously maintained. Decidualization, occurring within the specialized stromal tissue encapsulating the fetus and placenta, shapes local immune adaptation required for healthy pregnancy. Here, we identify a decidua-enriched effector-like memory CD8+ T cell subset marked by CD45RA in humans and CX3CR1 in mice. These cells preferentially accumulate in the decidua, which harbors a CX3CL1-dominant chemokine niche, and disruption of Cx3cr1 or uterine Cx3cl1 impaired their decidual recruitment and tissue localization. Human CD45RA+ and murine CX3CR1+ decidual memory CD8+ T cells shared conserved transcriptional and functional features, including enhanced cytotoxic potential and limited inflammatory cytokine production. Functionally, CX3CL1-mediated CD8+ T cell accumulation improved local control of prenatal Listeria monocytogenes infection and reduced infection-associated fetal loss. In contrast, fetal antigen-specific CD8+ T cell accumulation and fetal resorption occurred independently of uterine CX3CL1. Together, our findings define the maternal-fetal interface as an active immunological gatekeeper, that compartmentalizing CD8+ T cell-mediated antimicrobial adaptive immunity through the conserved CX3CL1-CX3CR1 axis, supporting pathogen-specific defense while preserving fetal tolerance.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological sex-dependent hormonal signaling and metabolomic profiles in obesity alter tumor microenvironment and immunotherapy outcomes. 生物性别依赖性激素信号和代谢组学特征在肥胖改变肿瘤微环境和免疫治疗的结果。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-03 DOI: 10.1172/JCI203453
Logan V Vick, Spencer R Rosario, Ziming Wang, Craig Collins, Lam T Khuat, Yatian Yang, Michael K Sheng, Wahed A Firoz, Ryan N Nielsen, Yao-Hui Sun, Aryana M Razmara, Hossein Borghaei, Emmanuel S Antonarakis, Andrew Elliott, Nishant Gandhi, Raid Aljumaily, Sami Ibrahimi, Michael Machiorlatti, Sara K Vesely, Shuchi Gulati, Sarbajit Mukherjee, Robert J Canter, Sean J Judge, Arta M Monjazeb, William J Murphy
{"title":"Biological sex-dependent hormonal signaling and metabolomic profiles in obesity alter tumor microenvironment and immunotherapy outcomes.","authors":"Logan V Vick, Spencer R Rosario, Ziming Wang, Craig Collins, Lam T Khuat, Yatian Yang, Michael K Sheng, Wahed A Firoz, Ryan N Nielsen, Yao-Hui Sun, Aryana M Razmara, Hossein Borghaei, Emmanuel S Antonarakis, Andrew Elliott, Nishant Gandhi, Raid Aljumaily, Sami Ibrahimi, Michael Machiorlatti, Sara K Vesely, Shuchi Gulati, Sarbajit Mukherjee, Robert J Canter, Sean J Judge, Arta M Monjazeb, William J Murphy","doi":"10.1172/JCI203453","DOIUrl":"https://doi.org/10.1172/JCI203453","url":null,"abstract":"<p><p>Commonly viewed as a negative prognostic factor in cancer, obesity is associated with improved responses to cancer immunotherapy using immune checkpoint inhibitors (ICIs). Although data suggest a sexual dimorphism influencing the effects of obesity on immunotherapy responses, to our knowledge, the intersection of sex and obesity on immunotherapy requires further exploration. We demonstrate, in a pan-cancer analysis stratified by sex and BMI, that obesity (BMI ≥ 30) is associated with improved survival after ICI only in male patients. In preclinical models of diet-induced obesity (DIO), we observed that only DIO male tumor-bearing mice responded better to ICI. The differential effect of sex on outcomes was associated with alterations in the tumor microenvironment where DIO female mice demonstrated increased tumor-associated macrophages skewed toward a M2 phenotype. Ovariectomy of DIO female mice reduced M2 polarization and increased anti-tumor immune responses including increases in tumor-infiltrating T cells following ICI. Metabolomic analysis of DIO mice demonstrated distinct profiles base on sex. Re-stratification of female cancer patients revealed that obesity was associated with improved outcome, but only in post-menopausal (age ≥ 55) patients. We identify that the immunotherapy \"obesity paradox\" is sex-dependent and that hormonal and metabolomic status modulates the influence of obesity on ICIs.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthetic immunological niche reveals early immune dysregulation and stratifies therapeutic response in type 1 diabetes. 合成免疫生态位揭示1型糖尿病早期免疫失调和分层治疗反应。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-03 DOI: 10.1172/JCI206433
Jyotirmoy Roy, Yifei Jiang, Runbo Mao, Jessica L King, Amod Talekar, Donglin Liu, Lillian Holman, Haoxuan Zeng, Xin Luo, Laila M Rad, Peter Sajjakulnukit, Brianna Ha, Kai Liu, Elizabeth J Bealer, Bryan Wonski, Kathryn Kang, Sean T Carey, Luke F Bugada, Brooke M Smiley, Shahzad Sohail, Antonio D Holmes, Dominik Awad, Aaron H Morris, Costas A Lyssiotis, Jie Liu, Lonnie D Shea
{"title":"Synthetic immunological niche reveals early immune dysregulation and stratifies therapeutic response in type 1 diabetes.","authors":"Jyotirmoy Roy, Yifei Jiang, Runbo Mao, Jessica L King, Amod Talekar, Donglin Liu, Lillian Holman, Haoxuan Zeng, Xin Luo, Laila M Rad, Peter Sajjakulnukit, Brianna Ha, Kai Liu, Elizabeth J Bealer, Bryan Wonski, Kathryn Kang, Sean T Carey, Luke F Bugada, Brooke M Smiley, Shahzad Sohail, Antonio D Holmes, Dominik Awad, Aaron H Morris, Costas A Lyssiotis, Jie Liu, Lonnie D Shea","doi":"10.1172/JCI206433","DOIUrl":"10.1172/JCI206433","url":null,"abstract":"<p><p>In Type 1 Diabetes (T1D), disease onset and immunotherapy responses vary widely, reflecting heterogeneous stage-specific immune dysregulation that remains undefined. To investigate this heterogeneity, we engineered microporous polycaprolactone scaffolds that form synthetic immunological niches (INs) subcutaneously and capture tissue-associated systemic immune changes. Building on our prior demonstration of IN-based longitudinal T1D monitoring, we use multimodal IN profiling to define the immune changes underlying divergent disease trajectories and immunotherapy responses. In non-obese diabetic (NOD) mice, longitudinal transcriptomic profiling of IN identified early myeloid associated changes, followed by increasing T cell-associated dysregulation that distinguished progressors from non-progressors. An early-stage IN-based T1D gene signature stratified NOD progressors from non-progressors by 6 weeks of age and was conserved across human T1D tissues, distinguishing T1D from non-diabetic individuals in spleen and pancreatic lymph node samples, but not in peripheral blood. Signature-based stratification revealed macrophage-associated TNFα pathway enrichment in pancreas of NOD progressors, which was validated in human T1D islets. Given the heterogeneous response to anti-TNFα therapy, IN profiling identified genesets associated with anti-TNFα efficacy and generated a response score that prospectively distinguished treatment-sensitive from resistant mice. These findings establish IN as a platform for detecting stage-wise immune dysregulation and stratifying immunotherapy response in T1D.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted gene therapy alleviates epilepsy and hyperexcitability in models of SCN2A deficiency. 靶向基因治疗减轻SCN2A缺乏症模型的癫痫和高兴奋性。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-03 DOI: 10.1172/JCI196068
Zaiyang Zhang, Jingliang Zhang, Xiaoling Chen, Brody A Deming, Shivam Kant, Purba Mandal, Harish Kothandaraman, Phillip J SanMiguel, Manasi S Halurkar, Akila D Abeyaratna, Morgan J Robinson, Iuliia Vitko, Ronald P Gaykema, Chongli Yuan, Nadia A Lanman, Matthew T Tegtmeyer, Dan Wang, Guangping Gao, Riyi Shi, Edward Perez-Reyes, Yang Yang
{"title":"Targeted gene therapy alleviates epilepsy and hyperexcitability in models of SCN2A deficiency.","authors":"Zaiyang Zhang, Jingliang Zhang, Xiaoling Chen, Brody A Deming, Shivam Kant, Purba Mandal, Harish Kothandaraman, Phillip J SanMiguel, Manasi S Halurkar, Akila D Abeyaratna, Morgan J Robinson, Iuliia Vitko, Ronald P Gaykema, Chongli Yuan, Nadia A Lanman, Matthew T Tegtmeyer, Dan Wang, Guangping Gao, Riyi Shi, Edward Perez-Reyes, Yang Yang","doi":"10.1172/JCI196068","DOIUrl":"https://doi.org/10.1172/JCI196068","url":null,"abstract":"<p><p>Pathogenic SCN2A loss-of-function (LoF) variants can cause severe, refractory epilepsy with limited treatment options. Existing Scn2a-LoF mouse models exhibit few spontaneous seizures, limiting the dynamic range needed to assess therapeutic efficacy. We therefore generated gene-trap Scn2a-deficient mice on the seizure-prone DBA/2J background. These mice experienced hundreds of spontaneous absence seizures per day, characterized by concurrent behavioral arrest and EEG spike-wave discharges (SWDs). Partial restoration of Scn2a expression reduced seizure burden. Electrophysiological analysis revealed impaired action potential waveforms yet increased repetitive firing, alongside coordinated downregulation of voltage-gated potassium channel genes, potentially contributing to hyperexcitability. Given the broad potassium channel downregulation and prior efficacy of KCNA1 gene therapy in refractory seizure models, we selected KV1.1 as a potential therapeutic target and used a drug-controllable adeno-associated virus (AAV) to express human KCNA1. We found that this intervention normalized elevated neuronal firing and reduced spontaneous seizure burden in Scn2a-deficient mice. Extending these findings to a human cell-based platform, AAV-mediated KCNA1 expression also reduced neuronal firing in human cortical organoids carrying a SCN2A-truncating variant identified in patients. Together, these findings provide proof of principle for drug-controllable KCNA1 gene therapy as a promising treatment avenue for epilepsy related to SCN2A LoF variants.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":" ","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response. 核cGAS控制转录以控制脂质代谢、肿瘤生长和治疗反应。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-02 DOI: 10.1172/JCI205579
Yu Deng, Matthew J Niederhuber, Zhichuan Zhu, Austin J Hepperla, Le Yu, Quentin Hahn, Joshua Hartsell, Tooba Rashid, Piotr A Mieczkowski, Hemant Kelkar, Jeremy M Simon, Yanqiong Zhang, Alessandra Livraghi-Butrico, Meredith J Zeller, Joseph Gc Kennedy, Jazmin F DePriest, Jiong Li, Yan Zhang, Xing Qiu, H Ümit Kaniskan, Jian Jin, Corbin D Jones, Laura E Herring, Douglas H Phanstiel, Xiaojing Liu, Jesse R Raab, Brian D Strahl, Pengda Liu
{"title":"Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response.","authors":"Yu Deng, Matthew J Niederhuber, Zhichuan Zhu, Austin J Hepperla, Le Yu, Quentin Hahn, Joshua Hartsell, Tooba Rashid, Piotr A Mieczkowski, Hemant Kelkar, Jeremy M Simon, Yanqiong Zhang, Alessandra Livraghi-Butrico, Meredith J Zeller, Joseph Gc Kennedy, Jazmin F DePriest, Jiong Li, Yan Zhang, Xing Qiu, H Ümit Kaniskan, Jian Jin, Corbin D Jones, Laura E Herring, Douglas H Phanstiel, Xiaojing Liu, Jesse R Raab, Brian D Strahl, Pengda Liu","doi":"10.1172/JCI205579","DOIUrl":"https://doi.org/10.1172/JCI205579","url":null,"abstract":"<p><p>Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor critical for host defense against microbial infections. To prevent aberrant activation, nuclear cGAS is restrained by nucleosome tethering or by barrier-to-autointegration factor-mediated restriction of its access to DNA. However, its physiological roles beyond enzymatic suppression in the nucleus remain poorly understood. Here, we present a genome-wide map of cGAS chromatin localization in human cells and unexpectedly find its binding beyond nucleosome tethering, where cGAS is recruited to chromatin by AP-1 transcription factors via a potentially previously uncharacterized transactivation domain. Integrated CUT&RUN, RNA-seq, and metabolomics analyses reveal that cGAS transcriptionally regulates cholesterol homeostasis. Mechanistically, cGAS promotes LGALS3 transcription, which inhibits ACAA2 activity to suppress fatty acid oxidation and acetyl-CoA production, thereby lowering intracellular cholesterol levels. Reduced cholesterol lowers plasma membrane phosphatidylinositol [3,4,5] triphosphate [PI(3,4,5)P3] levels and decreases mTOR complex 2 (mTORC2) activation. In contrast, cGAS depletion results in cholesterol accumulation and elevated PI(3,4,5)P3, driving mTORC2/Akt signaling, promoting xenografted tumor growth, and conferring resistance to DNA-damaging agents. In vivo, the elevated hepatic cholesterol levels observed in cGas-/- mice were largely reversed by inhibition of Akt but not STING, whereas cGAS deficiency had minimal effects on lung physiology. Collectively, our findings uncover an unexpected role for nuclear cGAS in orchestrating a transcriptional program that links lipid metabolism to cell proliferation, stress response, and cholesterol homeostasis in liver.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":"136 21","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary arterial hypertension-associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases. 肺动脉高压相关的小脑损伤为心脏代谢和神经退行性疾病提供了证据。
IF 14.3 1区 医学
Journal of Clinical Investigation Pub Date : 2026-11-02 DOI: 10.1172/JCI212006
Michael W Schwartz, Karin E Bornfeldt
{"title":"Pulmonary arterial hypertension-associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases.","authors":"Michael W Schwartz, Karin E Bornfeldt","doi":"10.1172/JCI212006","DOIUrl":"https://doi.org/10.1172/JCI212006","url":null,"abstract":"<p><p>Growing evidence shows that the risk of cognitive impairment is increased across a range of metabolic and cardiovascular diseases, but underlying mechanisms remain poorly understood. One possibility involves activation of microglia, a glial cell type of the central nervous system with morphological and transcriptional features comparable to resident macrophages in other tissues that plays specialized roles in supporting neuronal and brain function. Combining clinical investigation in pulmonary arterial hypertension (PAH) cohorts with mouse model and microglial cell culture studies, a study by Okawa, Shi, and colleagues in this issue of the JCI adds compelling, albeit indirect, evidence linking impaired lysosomal lipid handling in both endothelial cells and microglia to a specific neurological disorder associated with PAH. The findings open opportunities for understanding how cardiopulmonary disease predisposes to neurodegeneration.</p>","PeriodicalId":15469,"journal":{"name":"Journal of Clinical Investigation","volume":"136 21","pages":""},"PeriodicalIF":14.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书